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Dedifferentiated chondrosarcoma (DDCS) is a rare and aggressive bone tumor with poor prognosis. Primary DDCS
of the mobile spine is extremely rare, particularly in the cervical spine. We herein describe a first case of cervical
DDCS in an 81-year-old male presenting with a slowly growing mass. Radiographs showed an expansion of the
cortical contour of the C2 lamina and a soft tissue mass with punctate calcification. Magnetic resonance imaging
demonstrated a lobulated lesion expanding over the entire lamina and pedicles of C2 with the tumor protuberant
to the adjacent soft tissue. A complete tumor resection was performed. Histologically, the majority of the tumor
was a low-grade chondrosarcoma component. However, atypical spindle cells that had proliferated in a fascicular
pattern with a collagenous stroma, mimicking fibrosarcoma, were focally observed without a transitional zone, and
these features confirmed that the tumor was DDCS.
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Primary chondrosarcoma (CS) is the third most common
primary malignant tumor of bone [1]. There are several
classifications of CS. One is based on localization, namely,
central, peripheral and periosteal. Another one is based on
histology and by far the most common histological sub-
type is conventional CS. Additionally, there are also some
rare histological entities, clear-cell CS, mesenchymal CS,
and dedifferentiated CS (DDCS). Despite the continuous
development and progress made in diagnostic techniques
and auxiliary treatment, there is still no good treatment
for DDCS at present. The prognosis of the patients of
DDCS remains poor and the five-year survival rate of
DDCS ranges around 24% in the most recent European
series [2,3]. Because of its rarity, only a few large studies
regarding the demographic data of DDCS have been
reported. In one of these large series, Grimer et al. [2]
showed that almost two-third of the cases were located in
long bones of the peripheral skeleton, mainly the femur,
while the remaining one-third involved the axial skeleton.* Correspondence: ymatsu@ortho.med.kyushu-u.ac.jp
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distribution, and reproduction in any mediumHowever, DDCS arising in the mobile spine was unusual.
To our knowledge, this is the first case report of cervical
DDCS that provides the detailed radiological and histo-
logical findings along with a review of the literature.Case presentation
An 81-year-old male consulted our department with a
six-month history of swelling and mild cervical spinal
stiffness. He also noticed a slowly growing mass. He had
a history of malignant lymphoma that was treated by
multi-agent chemotherapy and had achieved a partial
remission. His physical examination was unremarkable
except for the presence of a hard upper cervical spine
mass. The clinical blood examination did not show any
abnormality. Radiographs of the cervical spine showed
an expansion of the cortical contour of the C2 lamina
and a soft tissue mass with punctate calcification.
Scalloping of the spinous process of C3 was also observed
(Figures 1a and b). The axial computed tomography (CT)
image (Figure 2a) demonstrated a soft-tissue mass with
an amorphous ‘rings and arcs’ calcified matrix and destruc-
tion of the entire C2 lamina. Importantly, these features
were also present in a CT image taken two years before the
presentation (Figure 2b) showing the tumor had expandedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Plain radiographs of the cervical spine ((a) lateral
view, (b) zoomed lateral view of the C2 spinous process)
showed an expansion of the cortical contour of the C2 lamina
and a soft-tissue mass with punctate calcification. Scalloping of
the spinous process of C3 was also observed.
Figure 3 Transverse T2 (a) and T1-weighted images at C2 (b),
a sagittal T2-weighted image (c) and T1-weighted image after
the intravenous administration of gadolinium (d), of the
cervical spine. During the MR imaging, the lesion exhibited a
lobulated lesion expanding over the entire lamina and pedicles of
C2 with the tumor protuberant to the adjacent soft tissue ((a) and
(b)). The mass was low-intensity on T1-weighted images and had
heterogeneous low and high-intensities on T2-weighted images,
suggesting the presence of mineralized and nonmineralized
matrices. Gadolinium-enhanced T1-weighted fat saturated images
showed intense peripheral and lobulated rim enhancement,
whereas lesions with limited mineralization may appear with
homogenous enhancement (d). MRI also showed the epidural
extension of the mass at the C2/3 level (c).
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(MRI) showed a lobulated lesion expanding over the entire
lamina and pedicles of C2 with the tumor protuberant
to the adjacent soft tissue. The mass was low-intensity
on T1-weighted imaging and had heterogeneous low
and high-intensities on T2-weighted imaging, thus
suggesting mineralized and nonmineralized matrices.
(Figures 3a and b) Gadolinium enhanced T1-weighted
fat saturated images showed intense peripheral and
lobulated rim enhancement, whereas lesions with limited
mineralization may appear with homogenous enhance-
ment (Figure 3d). MRI showed the epidural extension of
the mass at the C2/3 level (Figure 3c). All of these im-
aging findings, along with the clinical presentation,
suggested the chondrogenic nature of the mass, particu-
larly suggesting a low-grade CS. An open biopsy showed
multilobular proliferation of chondrocytic cells with
mild cellular atypia embedded in abundant chondroid
matrix, suggesting a grade I CS. A CT examination ofFigure 2 The axial computed tomography (CT) image
(a) demonstrated a soft-tissue mass with an amorphous ‘rings
and arcs’ calcified matrix and destruction of the C2 lamina. The
tumor at the C2 lamina was also observed in a CT image taken at two
years before presentation (b) and the tumor was noted to have
expanded during the follow up.the chest, abdomen, and pelvis was normal. A complete
intralesional resection of the tumor was performed by the
posterior approach, with instrumentation being placed
from C1 to C4 and fusion was then accomplished by an
autograft made with bone chips. Macroscopically, the
tumor was completely removed. The wound was exten-
sively irrigated and closed in multiple layers. There were
no neurological deficits and no wound problems were
observed postoperatively.
Microscopically, the majority of the tumor was composed
of the proliferation of chondrocytic cells with enlarged
hyperchromatic nuclei, accompanied by chondromyxoid
matrix and permeating bone trabeculae indicating low-
grade CS (Figures 4a and b). The low-grade (grade I) CS
component was demarcated to the atypical spindle cell
areas (Figure 4c). Atypical spindle cells proliferated in a
fascicular pattern with collagenous stroma mimicking
fibrosarcoma (Figure 4d), thus indicating it to be fibro-
sarcomatous dedifferentiation of CS. The extension of
high-grade component was around 10%. Together, these
findings led to a final diagnosis of DDCS because of the
Figure 4 Hematoxylin and eosin staining of surgical specimens: (a) The cartilaginous component was permeating into the normal
trabecular bone (x40) and showed well-differentiated conventional chondrosarcoma composed of atypical chondrocytes with hyaline
cartilage matrix (b) (x200). (c) (x40) and (d) (x100) Characteristic coexistence of conventional chondrosarcoma and dedifferentiated
components. The dedifferentiated components were composed of atypical spindle cells that had proliferated in a fascicular pattern with
collagenous stroma resembling fibrosarcoma.
Matsumoto et al. World Journal of Surgical Oncology 2013, 11:32 Page 3 of 6
http://www.wjso.com/content/11/1/32coexistence of conventional low-grade CS and dediffer-
entiated components with sharp margins. In an immuno-
histochemical analysis, the cartilaginous components were
positive for S-100 protein, but the spindle cell areas were
negative (Figure 5a). The Ki-67 antigen, a marker of cell
proliferation, was increased in the spindle cell areas, but
not in the cartilaginous component (Figure 5b). A post-
operative MRI and a CT scan performed four months after
the operation showed no evidence of local recurrence or
distant metastasis. However, six months after the surgery,
the patient died from rupture of the colon due to the
recurrence of malignant lymphoma.
Discussion
The term DDCS was introduced in 1971 [4]. It is thought
that up to 11% of low-grade CS contain an additional
component of high-grade mesenchymal sarcoma features,
including conventional osteosarcoma, malignant fibrous
histiocytoma, fibrosarcoma or anaplastic spindle-cell sar-
coma [5]. These dedifferentiated components are thought
to be related to the characteristic clinical features of
DDCS, such as its locally aggressive behavior, frequency of
recurrence and, poor prognosis. DDCS usually affects long
bones such as the proximal femur, humerus and tibia.DDCS in the spine is extremely rare, and to the best of
our knowledge, this is the first case of DDCS in the
cervical spine reported in detail. The clinical course of
low-grade CS originating in the spine is usually long
because of the slow growth of the tumor [6]. However,
treatment of DDCS in the spine would be complex and
challenging because of its clinical features as discussed
above.
In the 57 cases of DDCS reported, calcification was
found in around 50% of the lesions and an extraosseous
mass was observed in roughly 55% of tumors [5]. CT is
able to clearly demonstrate these features as well the ana-
tomic origin of the lesion [7]. In this case, the origin of the
tumor was thought to be the C2 lamina, which was
confirmed by successive CT images (Figures 2a and b).
MRI demonstrates the tumor as a low-signal intensity
region on T1-weighted images and as heterogeneous
low and high-signal intensities on T2-weighted images,
thus suggesting the presence of mineralized and non-
mineralized matrices. Fat suppressed contrast-enhanced
T1-weighted images show peripheral and lobulated rim
enhancement, whereas lesions with limited calcification
may appear with homogenous enhancement, know as
‘rings and arcs pattern’ [8]. Notably, MRI is superior to
Figure 5 In the immunohistochemical analysis, the
cartilaginous components were positive for S-100 protein, but
the spindle cell areas were negative (a) (x100). (bcp (x100) Ki-67
antigen, a marker of cell proliferation, was increased in the spindle
cell areas, while it was absent in the cartilaginous component.
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extension [9], as was seen in this case. Even if the biopsy
results show low-grade CS, excluding a diagnosis of high-
grade chondrosarcoma, clinicians should consider the pos-
sibility of DDCS in patients with destructive bone lesions
and prominent soft tissue masses.
CS, particularly DDCS, is known to be resistant to the
chemotherapy and radiotherapy. Thus, surgery remains
the only potentially curative treatment for DDCS. The
local recurrence rate of DDCS rate was over 50% in pre-
vious studies, but this decreased after radical surgery
with a clean surgical margin [10,11]. Regarding the treat-
ment of spinal tumor, en bloc resection with negative
margins has been shown to decrease the rates of local
and metastatic recurrence [12,13]. Therefore, an en bloc
resection, if possible, is now recommended for many pri-
mary tumors of the thoracic, lumbar, and sacral spine.
However, in cases affecting the cervical spine, theproximity of the vertebral arteries, the complex bony
structure, and the importance of the cervical nerve roots
prevent the use of an ideal en bloc resection [14]. In
the present case, total en bloc resection of the tumor
was practically impossible because of the bilateral tumor
invasion into the C2 pedicle, so tumor curettage was
performed. Although the tumor was totally removed
macroscopically, the recurrence of the tumor was thought
to be inevitable and a careful postoperative observation
would be needed in such case.
As mentioned above, DDCS is not sensitive to radio-
therapy. However, if the tumor cannot be completely
resected, or in cases of local recurrence, radiotherapy
should be considered. Conventional radiotherapy using
spinal cord dose limits of 45 to 50 Gy, given to the full
cross section of the cord, is well below the dose needed
to control most sarcomas including CS [15]. Therefore,
innovative modalities of radiotherapy are necessary to
safely irradiate these tumors with an intension to cure.
In this regard, proton/photon beam radiation is promis-
ing because of its excellent physical dose distribution
and intensity modulation, which largely spares the spinal
cord. A pilot study of patients with axial skeleton tumors
treated with combined high-dose proton/photon radi-
ation showed satisfactory rates of local control (LC). For
CS, LC was achieved in six out of six patients with a
mean target dose of 73.9 gray equivalent (GyE), although
the histological subtype of CS was not specified in that
study [16]. The use of heavier charged particles, in par-
ticular carbon ions, would be another interesting alter-
native. Kamada et al. [17] reported the results of a Phase
I/II study of carbon- ion RT in 57 patients with 64 sites
of unresectable sarcomas of bone and soft tissue and a
total of 19 patients with spinal or paraspinal tumors
were enrolled. The total dose given was 52.8 to 73.6
carbon GyE. In this study, the LC rates for CS were
71% (5 out of 7 patients) without unacceptable morbidity.
These results suggest that proton/photon radiation and
carbon-ion RT may provide an effective, safe local treat-
ment for patients with cervical spine CS [17].
Distant metastasis, particularly lung metastasis, is the
main cause of death due to DDCS and the development
of effective adjuvant chemotherapy regimens to control
distant metastasis is critical for improving the prognosis
of DDCS. However, as mentioned above, DDCS is known
to be resistant to chemotherapy. The efficacy of adjuvant
chemotherapy has been reported in 23 patients out of 42
cases of DDCS [18]. The five-year survival rates of the
patients treated with surgery alone and those treated with
adjuvant chemotherapy were 11.8% and 4%, and the
median survival time was 6.4 months and 8.4 months,
respectively, so the authors concluded that adjuvant chemo-
therapy did not extend survival. Meanwhile, Mitchell et al.
suggested that there was an improved survival in the DDCS
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chemotherapy, although subsequent papers have failed to
confirm this [10,19]. Large population clinical data to de-
termine which regimen of chemotherapy can prolong the
survival of the patients with DDCS are needed.
An abrupt interface between the low-grade cartilaginous
and high-grade sarcomatous components is a critical
histological feature of DDCS. In the literature, the
dedifferentiated component of DDCS could be variable,
including conventional osteosarcoma, malignant fibrous
histiocytoma, fibrosarcoma, anaplastic spindle-cell sar-
coma or telangiectatic osteosarcoma [5]. In this case, the
majority of the tumor was a low-grade CS component and
atypical spindle cell proliferation in a fascicular pattern
with collagenous stroma, mimicking fibrosarcoma, was
focally seen. Some of these cells were positive for the
Ki-67 antigen, suggesting the highly proliferative nature
of these cells. Recent reports have shown that only
the dedifferentiated component of the DDCS may
cause distant metastasis, particularly to the lungs, and
metastasis-related genes including Urokinase and Tissue
plasminogen activator are expressed in the metastatic lung
lesions [20]. The results of molecular analyses that dissect
the molecular mechanisms underlying metastasis in DDCS
would therefore help to improve the future treatment
of DDCS.Conclusion
We herein reported the first detailed case of DDCS in
the cervical spine. Histologically, the low-grade chondro-
sarcoma component and atypical spindle cells resembling
fibrosarcoma were observed in the resected tumor without
a transitional zone. These features confirmed that the
tumor was DDCS.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the editor-in-chief of this journal.
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